Experiences and preferences about information on treatment-related side effects among patients with early breast cancer
Background: Treatment-related side effects are common among women treated for early breast cancer and their effective management is essential to maintain quality of life, ensure treatment adherence, and optimise survival outcomes. This study aimed to investigate patient-reported experiences and pref...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Breast |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977625000335 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849343581950574592 |
|---|---|
| author | Antonio Di Meglio Giuseppe Catanuto Marzia Zambon Alexandre Chan Angelos P. Kassianos Constantina Cloconi Silvia Rohr Rebecca Steele Monique Coersmeyer Sonia Ujupan Fedro Peccatori |
| author_facet | Antonio Di Meglio Giuseppe Catanuto Marzia Zambon Alexandre Chan Angelos P. Kassianos Constantina Cloconi Silvia Rohr Rebecca Steele Monique Coersmeyer Sonia Ujupan Fedro Peccatori |
| author_sort | Antonio Di Meglio |
| collection | DOAJ |
| description | Background: Treatment-related side effects are common among women treated for early breast cancer and their effective management is essential to maintain quality of life, ensure treatment adherence, and optimise survival outcomes. This study aimed to investigate patient-reported experiences and preferences about information regarding side effects received during breast cancer care. Methods: An international multi-stakeholder expert group conducted an online patient survey assessing comprehensiveness, timing, and delivery modality of information regarding treatment-related side effects among patients undergoing primary therapy (surgery, radiation, and [neo]adjuvant chemotherapy) and endocrine therapy for early breast cancer. Descriptive analyses were performed. Results: From June–August 2023, 608 respondents from Brazil, France, Germany, Italy, Japan, and Spain completed the survey: 57.5 % were <50 years old, and all were or had been on endocrine therapy. Fatigue was the most reported side effect (47.0 % for primary and 42.3 % for endocrine therapy). A variable proportion of patients (14.4%–46.8 % across side effects) reported receiving information only after having experienced the side effect. Up to 43.6 % of respondents reported receiving insufficient or no information on side effects from their healthcare providers. Most patients reported preference for proactive communication from healthcare providers about side effects and prevention strategies. Respondents valued direct interactions with physicians and nurses and capitalised on a relevant role for peer-support, however utility of smartphone and web-based platforms to record and manage symptoms was acknowledged. Conclusion: The survey underscores critical needs and offers insight informing the provision of comprehensive and timely information on treatment-related side effects across the cancer survivorship continuum. |
| format | Article |
| id | doaj-art-483eb83991a64cd5bcb3dc17ec90ad9f |
| institution | Kabale University |
| issn | 1532-3080 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Breast |
| spelling | doaj-art-483eb83991a64cd5bcb3dc17ec90ad9f2025-08-20T03:42:56ZengElsevierBreast1532-30802025-04-018010441410.1016/j.breast.2025.104414Experiences and preferences about information on treatment-related side effects among patients with early breast cancerAntonio Di Meglio0Giuseppe Catanuto1Marzia Zambon2Alexandre Chan3Angelos P. Kassianos4Constantina Cloconi5Silvia Rohr6Rebecca Steele7Monique Coersmeyer8Sonia Ujupan9Fedro Peccatori10Cancer Survivorship Program, INSERM Unit 981, Gustave Roussy, Villejuif, France; Corresponding author. Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France.European Society of Surgical Oncology (ESSO), Brussels, Belgium and Humanitas Istituto Clinico Catanese, Misterbianco, Catania, ItalyEuropa Donna – the European Breast Cancer Coalition, Milano, ItalyUniversity of California, School of Pharmacy & Pharmaceutical Sciences, Irvine, USADepartment of Nursing, Cyprus University of Technology, Limassol, CyprusEuropean Oncology Nursing Society, Brussels, Belgium and German Oncology Center, Limassol, CyprusVintura BV, Utrecht, NetherlandsVintura BV, Utrecht, NetherlandsEli Lilly and Company, Belgium / Vernier, Brussels, SwitzerlandEli Lilly and Company, Belgium / Vernier, Brussels, SwitzerlandEuropean Institute of Oncology IRCCS, Milano, ItalyBackground: Treatment-related side effects are common among women treated for early breast cancer and their effective management is essential to maintain quality of life, ensure treatment adherence, and optimise survival outcomes. This study aimed to investigate patient-reported experiences and preferences about information regarding side effects received during breast cancer care. Methods: An international multi-stakeholder expert group conducted an online patient survey assessing comprehensiveness, timing, and delivery modality of information regarding treatment-related side effects among patients undergoing primary therapy (surgery, radiation, and [neo]adjuvant chemotherapy) and endocrine therapy for early breast cancer. Descriptive analyses were performed. Results: From June–August 2023, 608 respondents from Brazil, France, Germany, Italy, Japan, and Spain completed the survey: 57.5 % were <50 years old, and all were or had been on endocrine therapy. Fatigue was the most reported side effect (47.0 % for primary and 42.3 % for endocrine therapy). A variable proportion of patients (14.4%–46.8 % across side effects) reported receiving information only after having experienced the side effect. Up to 43.6 % of respondents reported receiving insufficient or no information on side effects from their healthcare providers. Most patients reported preference for proactive communication from healthcare providers about side effects and prevention strategies. Respondents valued direct interactions with physicians and nurses and capitalised on a relevant role for peer-support, however utility of smartphone and web-based platforms to record and manage symptoms was acknowledged. Conclusion: The survey underscores critical needs and offers insight informing the provision of comprehensive and timely information on treatment-related side effects across the cancer survivorship continuum.http://www.sciencedirect.com/science/article/pii/S0960977625000335 |
| spellingShingle | Antonio Di Meglio Giuseppe Catanuto Marzia Zambon Alexandre Chan Angelos P. Kassianos Constantina Cloconi Silvia Rohr Rebecca Steele Monique Coersmeyer Sonia Ujupan Fedro Peccatori Experiences and preferences about information on treatment-related side effects among patients with early breast cancer Breast |
| title | Experiences and preferences about information on treatment-related side effects among patients with early breast cancer |
| title_full | Experiences and preferences about information on treatment-related side effects among patients with early breast cancer |
| title_fullStr | Experiences and preferences about information on treatment-related side effects among patients with early breast cancer |
| title_full_unstemmed | Experiences and preferences about information on treatment-related side effects among patients with early breast cancer |
| title_short | Experiences and preferences about information on treatment-related side effects among patients with early breast cancer |
| title_sort | experiences and preferences about information on treatment related side effects among patients with early breast cancer |
| url | http://www.sciencedirect.com/science/article/pii/S0960977625000335 |
| work_keys_str_mv | AT antoniodimeglio experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer AT giuseppecatanuto experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer AT marziazambon experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer AT alexandrechan experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer AT angelospkassianos experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer AT constantinacloconi experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer AT silviarohr experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer AT rebeccasteele experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer AT moniquecoersmeyer experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer AT soniaujupan experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer AT fedropeccatori experiencesandpreferencesaboutinformationontreatmentrelatedsideeffectsamongpatientswithearlybreastcancer |